2024 Q2 Form 10-Q Financial Statement

#000162828024022348 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $459.0K $415.0K $233.0K
YoY Change 50.49% 78.11% 19.49%
Cost Of Revenue $210.0K $280.0K $141.0K
YoY Change 28.83% 98.58% 34.29%
Gross Profit $249.0K $135.0K $92.00K
YoY Change 75.35% 46.74% 2.22%
Gross Profit Margin 54.25% 32.53% 39.48%
Selling, General & Admin $1.384M $1.608M $1.750M
YoY Change -21.41% -8.11% -8.23%
% of Gross Profit 555.82% 1191.11% 1902.17%
Research & Development $467.0K $370.0K $359.0K
YoY Change 22.57% 3.06% -23.62%
% of Gross Profit 187.55% 274.07% 390.22%
Depreciation & Amortization $36.00K $37.00K $36.00K
YoY Change 9.09% 2.78% -45.45%
% of Gross Profit 14.46% 27.41% 39.13%
Operating Expenses $1.851M $1.978M $2.137M
YoY Change -13.59% -7.44% -11.8%
Operating Profit -$1.602M -$1.843M -$2.045M
YoY Change -19.9% -9.88% -12.34%
Interest Expense $17.00K $11.00K $8.000K
YoY Change 142.86% 37.5% 700.0%
% of Operating Profit
Other Income/Expense, Net $18.00K $11.00K $8.000K
YoY Change 157.14% 37.5%
Pretax Income -$1.584M -$1.832M -$2.037M
YoY Change -20.52% -10.06% -12.65%
Income Tax
% Of Pretax Income
Net Earnings -$1.584M -$1.832M -$2.037M
YoY Change -20.52% -10.06% -12.65%
Net Earnings / Revenue -345.1% -441.45% -874.25%
Basic Earnings Per Share -$3.08 -$0.36 -$11.91
Diluted Earnings Per Share -$3.08 -$0.36 -$1.32
COMMON SHARES
Basic Shares Outstanding 5.145M shares 5.145M shares 2.053M shares
Diluted Shares Outstanding 514.5K shares 5.145M shares 171.0K shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.952M $3.562M $2.748M
YoY Change -11.11% 29.62% -61.91%
Cash & Equivalents $2.000M $3.600M $2.748M
Short-Term Investments
Other Short-Term Assets $464.0K $346.0K $450.0K
YoY Change 40.61% -23.11% 60.14%
Inventory $899.0K $874.0K $815.0K
Prepaid Expenses $464.0K $346.0K
Receivables $243.0K $161.0K $46.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.558M $4.943M $4.059M
YoY Change 6.69% 21.78% -52.24%
LONG-TERM ASSETS
Property, Plant & Equipment $360.0K $353.0K $564.0K
YoY Change 46.94% -37.41% -29.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.00K $22.00K $22.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $479.0K $529.0K $586.0K
YoY Change -9.28% -9.73% -27.2%
TOTAL ASSETS
Total Short-Term Assets $3.558M $4.943M $4.059M
Total Long-Term Assets $479.0K $529.0K $586.0K
Total Assets $4.037M $5.472M $4.645M
YoY Change 4.5% 17.8% -50.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $191.0K $116.0K $215.0K
YoY Change 59.17% -46.05% -11.89%
Accrued Expenses $415.0K $391.0K $768.0K
YoY Change -33.17% -49.09% 21.14%
Deferred Revenue $15.00K $15.00K
YoY Change -37.5%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $39.00K $34.00K
YoY Change
Total Short-Term Liabilities $761.0K $715.0K $1.016M
YoY Change -20.15% -29.63% 13.65%
LONG-TERM LIABILITIES
Long-Term Debt $162.0K $147.0K $0.00
YoY Change
Other Long-Term Liabilities $132.0K
YoY Change -72.67%
Total Long-Term Liabilities $162.0K $147.0K $132.0K
YoY Change 95.18% 11.36% -72.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $761.0K $715.0K $1.016M
Total Long-Term Liabilities $162.0K $147.0K $132.0K
Total Liabilities $923.0K $862.0K $1.148M
YoY Change -10.91% -24.91% -16.63%
SHAREHOLDERS EQUITY
Retained Earnings -$133.3M -$131.7M
YoY Change 5.63%
Common Stock $1.000K $5.000K
YoY Change -66.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.114M $4.610M $3.497M
YoY Change
Total Liabilities & Shareholders Equity $4.037M $5.472M $4.645M
YoY Change 4.5% 17.8% -50.08%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.584M -$1.832M -$2.037M
YoY Change -20.52% -10.06% -12.65%
Depreciation, Depletion And Amortization $36.00K $37.00K $36.00K
YoY Change 9.09% 2.78% -45.45%
Cash From Operating Activities -$1.587M -$1.829M -$2.015M
YoY Change -8.9% -9.23% -0.69%
INVESTING ACTIVITIES
Capital Expenditures $39.00K $2.000K $1.000K
YoY Change 95.0% 100.0% -101.52%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$39.00K -$2.000K -$1.000K
YoY Change 95.0% 100.0% -98.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.00K -$2.000K -11.00K
YoY Change -98.68% -81.82% -31.25%
NET CHANGE
Cash From Operating Activities -1.587M -$1.829M -2.015M
Cash From Investing Activities -39.00K -$2.000K -1.000K
Cash From Financing Activities 16.00K -$2.000K -11.00K
Net Change In Cash -1.610M -$1.833M -2.027M
YoY Change 191.67% -9.57% -3.98%
FREE CASH FLOW
Cash From Operating Activities -$1.587M -$1.829M -$2.015M
Capital Expenditures $39.00K $2.000K $1.000K
Free Cash Flow -$1.626M -$1.831M -$2.016M
YoY Change -7.72% -9.18% 2.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
280000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
141000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5140024 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5140024 shares
CY2024Q1 us-gaap Gross Profit
GrossProfit
135000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
92000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
370000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
387000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1608000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1750000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1978000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2137000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1843000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2045000 usd
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
15000 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
8000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
4000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1832000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1832000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2037000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2037000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5144531 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5144531 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171047 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171047 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.91
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.91
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1832000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2037000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
85000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
166000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-2000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
66000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-42000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-28000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
79000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-38000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-34000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-325000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
23000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-11000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1829000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2015000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-8000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
CY2024Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6000 usd
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1833000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2027000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5395000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4775000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3562000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2748000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
4000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 snes Number Of States Registration Received
NumberOfStatesRegistrationReceived
50 state
CY2024Q1 snes Number Of States Approved Removal Of Restricted Use Designation
NumberOfStatesApprovedRemovalOfRestrictedUseDesignation
49 state
CY2024Q1 snes Number Of Major Us Territories Registration Received
NumberOfMajorUSTerritoriesRegistrationReceived
5 territory
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131700000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3600000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in our financial statements include the valuation of inventory, common stock warrants, and stock-based awards, such as stock options and restricted stock units. Actual results could differ from such estimates.</span></div>
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
61000 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
41000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3600000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5400000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
165000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
99000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
161000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
797000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
747000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
11000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
71000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
53000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
879000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
800000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
874000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
795000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2024Q1 snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
CY2023Q1 snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
CY2024Q1 snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
0 usd
CY2023Q1 snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
0 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2024Q1 snes Prepaid Software Licenses Current
PrepaidSoftwareLicensesCurrent
139000 usd
CY2023Q4 snes Prepaid Software Licenses Current
PrepaidSoftwareLicensesCurrent
152000 usd
CY2024Q1 snes Professional Services Retainer
ProfessionalServicesRetainer
66000 usd
CY2023Q4 snes Professional Services Retainer
ProfessionalServicesRetainer
30000 usd
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
49000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
64000 usd
CY2024Q1 snes Deposit.Equipment Purchase Current
Deposit.EquipmentPurchaseCurrent
25000 usd
CY2023Q4 snes Deposit.Equipment Purchase Current
Deposit.EquipmentPurchaseCurrent
0 usd
CY2024Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
9000 usd
CY2023Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
14000 usd
CY2024Q1 snes Prepaid Inventory Current
PrepaidInventoryCurrent
8000 usd
CY2023Q4 snes Prepaid Inventory Current
PrepaidInventoryCurrent
111000 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
50000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
17000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
346000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
388000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2456000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2419000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
353000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
388000 usd
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
285000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
232000 usd
CY2024Q1 snes Legal Services Current
LegalServicesCurrent
27000 usd
CY2023Q4 snes Legal Services Current
LegalServicesCurrent
121000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
12000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
15000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
67000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
391000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
368000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
56000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
56000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
164000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
164000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
159000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36708 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
119.70
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
41 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
300.62
CY2024Q1 snes Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresWeightedAverageRemainingContractualTerm
3.0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36667 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
119.49
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
166000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6351000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000 usd
CY2024Q1 snes Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
6000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1832000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4610000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5279000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
166000 usd
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-11000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2037000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3497000 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7775734 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.95
CY2023 snes Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
P3Y4M24D
CY2024Q1 snes Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
4608 shares
CY2024Q1 snes Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
1.30
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7771126 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.95
CY2024Q1 snes Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
P3Y1M6D
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
288772 shares
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001628280-24-022348-index-headers.html Edgar Link pending
0001628280-24-022348-index.html Edgar Link pending
0001628280-24-022348.txt Edgar Link pending
0001628280-24-022348-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snes-20240331.htm Edgar Link pending
snes-20240331.xsd Edgar Link pending
snes-20240331xex311.htm Edgar Link pending
snes-20240331xex312.htm Edgar Link pending
snes-20240331xex321.htm Edgar Link pending
snes-20240331xex322.htm Edgar Link pending
snes-20240331_cal.xml Edgar Link unprocessable
snes-20240331_def.xml Edgar Link unprocessable
snes-20240331_lab.xml Edgar Link unprocessable
snes-20240331_pre.xml Edgar Link unprocessable
snes-20240331_htm.xml Edgar Link completed